1. Home
  2. OSIS vs PRAX Comparison

OSIS vs PRAX Comparison

Compare OSIS & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OSIS
  • PRAX
  • Stock Information
  • Founded
  • OSIS 1987
  • PRAX 2015
  • Country
  • OSIS United States
  • PRAX United States
  • Employees
  • OSIS N/A
  • PRAX N/A
  • Industry
  • OSIS Industrial Machinery/Components
  • PRAX Biotechnology: Pharmaceutical Preparations
  • Sector
  • OSIS Technology
  • PRAX Health Care
  • Exchange
  • OSIS Nasdaq
  • PRAX Nasdaq
  • Market Cap
  • OSIS 4.2B
  • PRAX 4.0B
  • IPO Year
  • OSIS 1997
  • PRAX 2020
  • Fundamental
  • Price
  • OSIS $247.94
  • PRAX $178.75
  • Analyst Decision
  • OSIS Strong Buy
  • PRAX Strong Buy
  • Analyst Count
  • OSIS 6
  • PRAX 13
  • Target Price
  • OSIS $247.50
  • PRAX $202.85
  • AVG Volume (30 Days)
  • OSIS 130.7K
  • PRAX 1.4M
  • Earning Date
  • OSIS 10-30-2025
  • PRAX 11-07-2025
  • Dividend Yield
  • OSIS N/A
  • PRAX N/A
  • EPS Growth
  • OSIS 18.02
  • PRAX N/A
  • EPS
  • OSIS 8.71
  • PRAX N/A
  • Revenue
  • OSIS $1,713,166,000.00
  • PRAX $7,765,000.00
  • Revenue This Year
  • OSIS $8.75
  • PRAX N/A
  • Revenue Next Year
  • OSIS $5.21
  • PRAX $20.00
  • P/E Ratio
  • OSIS $28.42
  • PRAX N/A
  • Revenue Growth
  • OSIS 11.33
  • PRAX 338.45
  • 52 Week Low
  • OSIS $129.84
  • PRAX $26.70
  • 52 Week High
  • OSIS $257.41
  • PRAX $205.89
  • Technical
  • Relative Strength Index (RSI)
  • OSIS 52.80
  • PRAX 80.27
  • Support Level
  • OSIS $241.24
  • PRAX $164.75
  • Resistance Level
  • OSIS $257.19
  • PRAX $192.96
  • Average True Range (ATR)
  • OSIS 7.95
  • PRAX 11.99
  • MACD
  • OSIS -0.75
  • PRAX 13.57
  • Stochastic Oscillator
  • OSIS 41.58
  • PRAX 82.53

About OSIS OSI Systems Inc. (DE)

OSI Systems Inc is a designer and manufacturer of electronic systems and components for businesses in the homeland security, healthcare, defense, and aerospace markets. The firm is organized in three business segments: Security, which derives maximum revenue, provides security and inspection systems; Healthcare, which provides patient monitoring, diagnostic, cardiology, ventilation systems, and defibrillators; and Optoelectronics and Manufacturing, which provides specialized electronic components and manufacturing services for the Security and Healthcare segments and external original equipment manufacturers. The majority of the firm's revenue is generated in the United States, and the rest from Mexico, Europe, the Middle East and Africa, and the Asia Pacific regions.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Share on Social Networks: